What is DrugCard?
DrugCard is a SaaS pharmacovigilance platform purpose-built to automate local and global medical literature screening for Marketing Authorization Holders (MAHs), Contract Research Organizations (CROs), and independent pharmacovigilance consultants. The platform monitors over 1,000 local journals across 55+ countries, supports screening in more than 100 languages, and applies proprietary OCR technology that achieves up to 99% recognition accuracy on poorly scanned texts — a technically critical threshold for journals in lower-income markets where digital formatting standards vary widely. Manual literature screening is one of the highest-cost recurring compliance obligations in pharmacovigilance. A single drug's GVP-compliant monitoring program across multiple regions can require a specialist to review dozens of local journals per month, translating non-English content and logging adverse event signals that may appear in obscure regional publications. DrugCard replaces this process with automated, auditable screening that records every step in a traceable log ready for regulatory inspection — with FDA 21 CFR Part 11-compliant records and signatures, plus a certificate of conformity for EU, US, and CIS regions, hosted on ISO/IEC 27001:2013 and SOC 2 Type II certified infrastructure. New journals and markets can be integrated within 2–3 weeks of request. DrugCard is not appropriate for organizations that need a full end-to-end adverse event case management system — it is a screening and monitoring platform, and case processing workflows require integration with a separate safety database such as Argus Safety or Oracle Empirica. Teams looking for open-access systematic review automation for academic literature should evaluate DistillerSR, which is designed for PRISMA-compliant review workflows rather than regulatory pharmacovigilance contexts. A free 2-week trial is available without committing to a subscription.
DrugCard is an AI-powered pharmacovigilance platform that automates local literature screening across 1,000+ journals in 55+ countries and 100+ languages, with OCR accuracy up to 99% and a free 2-week trial.
DrugCard is widely used by professionals, developers, marketers, and creators to enhance their daily work and improve efficiency.
Key Features
Pros & Cons
Who Uses DrugCard?
DrugCard vs MyMap AI vs GPT for Sheets and Docs vs Pabbly Connect
Detailed side-by-side comparison of DrugCard with MyMap AI, GPT for Sheets and Docs, Pabbly Connect — pricing, features, pros & cons, and expert verdict.
| Compare | ||||
|---|---|---|---|---|
Pricing |
Free | Freemium | Freemium | Freemium |
Rating |
— | — | — | — |
Free Trial |
✓ | ✓ | ✓ | ✓ |
Key Features |
|
|
|
|
Pros |
DrugCard customers report 50–70% reductions in time spe The platform achieves 99% keyword recognition accuracy By replacing specialist reading hours with automated AI | Converting a 30-page document or a complex topic descri The chat-based creation model means there is no interfa MyMap accepts source material from text, documents, URL | Running a language model prompt across an entire Google The freemium model provides access to base AI processin The add-on integrates as a standard Google Workspace si | Features a logical, step-by-step wizard that simplifies The lifetime deal provides massive long-term ROI, espec Backed by an active Facebook group of 21,000+ members a |
Cons |
Configuring DrugCard for a specific drug safety monitor While DrugCard's standard configuration covers the majo | The chat-based creation model is intuitive for simple d MyMap AI requires an active internet connection for all MyMap's AI-driven layout produces diagrams that are str | While the formula syntax is straightforward, writing ef GPT-4 Turbo and Claude 3 model calls generate token-bas GPT for Sheets and Docs operates exclusively within Goo | While no-code, mastering the logic of deep routers and While it covers 2,000+ apps, some niche enterprise trig Workflow reliability is tied to the API stability of th |
Best For |
Contract Research Organizations (CROs) | Students & Researchers | Content Creators | Small to Medium-Sized Businesses |
Verdict |
For CROs and MAHs managing multi-region literature monitorin… | MyMap AI is the most accessible entry point for AI-generated… | For e-commerce managers, data analysts, and content teams wh… | Pabbly Connect is the 'utility player' of the automation wor… |
Try It |
Visit DrugCard ↗ | Visit MyMap AI ↗ | Visit GPT for Sheets and Docs ↗ | Visit Pabbly Connect ↗ |
DrugCard vs MyMap AI vs GPT for Sheets and Docs vs Pabbly Connect — Which is Better in 2026?
Choosing between DrugCard, MyMap AI, GPT for Sheets and Docs, Pabbly Connect can be difficult. We compared these tools side-by-side on pricing, features, ease of use, and real user feedback.
DrugCard vs MyMap AI
DrugCard — DrugCard is an AI Tool that addresses one of pharmacovigilance's most resource-intensive compliance requirements — local literature monitoring — through automat
MyMap AI — MyMap AI is an AI Tool that generates diagrams and mind maps from conversational input, uploaded files, URLs, and live web search results. Its chat-native desig
- DrugCard: Best for Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), Pharmacovigilance Fr
- MyMap AI: Best for Students & Researchers, Professionals, Content Creators, Educators, Uncommon Use Cases
DrugCard vs GPT for Sheets and Docs
DrugCard — DrugCard is an AI Tool that addresses one of pharmacovigilance's most resource-intensive compliance requirements — local literature monitoring — through automat
GPT for Sheets and Docs — GPT for Sheets and Docs is an AI Tool that brings multiple AI language models into Google Sheets and Docs through a simple add-on installation, enabling bulk te
- DrugCard: Best for Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), Pharmacovigilance Fr
- GPT for Sheets and Docs: Best for Content Creators, Data Analysts, E-commerce Managers, Marketers, Uncommon Use Cases
DrugCard vs Pabbly Connect
DrugCard — DrugCard is an AI Tool that addresses one of pharmacovigilance's most resource-intensive compliance requirements — local literature monitoring — through automat
Pabbly Connect — Pabbly Connect is a high-value automation engine that disrupts the market with its 'pay-once' lifetime model. By offering 2,000+ integrations and a generous pol
- DrugCard: Best for Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), Pharmacovigilance Fr
- Pabbly Connect: Best for Small to Medium-Sized Businesses, E-commerce Platforms, Marketing Agencies, Freelancers, Uncommon Us
Final Verdict
For CROs and MAHs managing multi-region literature monitoring obligations, DrugCard reduces the per-drug compliance burden from specialist hours to automated screening cycles with audit-ready output — its proprietary OCR accuracy at poorly scanned journal content is the technical differentiator that regional manual screening cannot match. The primary limitation is that DrugCard handles monitoring and screening only; adverse event case processing requires a separate safety database integration, making it a component in a broader pharmacovigilance stack rather than a standalone solution.
FAQs
4 questionsExpert Verdict
Summary
DrugCard is an AI Tool that addresses one of pharmacovigilance's most resource-intensive compliance requirements — local literature monitoring — through automated multilingual screening with full audit traceability. Customer feedback validates 50–70% time savings over manual processes, and the platform's regulatory infrastructure covers FDA, EU, and CIS compliance requirements out of the box. It operates as a focused screening module rather than a complete safety database, requiring integration with case management systems for end-to-end pharmacovigilance workflow coverage.
It is suitable for beginners as well as professionals who want to streamline their workflow and save time using advanced AI capabilities.
User Reviews
0 reviewsAlternatives to DrugCard
6 tools
